title: Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B.
abstract: The aim of this study was to assess the effect of 48-week entecavir therapy on serum and intrahepatic hepatitis B virus, covalently closed circular DNA (HBV cccDNA) levels in hepatitis B e antigen (HBeAg)-positive patients. A total of 120 patients with HBeAg-positive chronic hepatitis were treated with entecavir for 48 weeks. Serum HBV markers, total HBV DNA, and HBV cccDNA levels were measured at baseline and week 48. Biopsies from 20 patients were available for both intrahepatic total HBV DNA and cccDNA testing at these timepoints. HBV cccDNA levels were decreased from a median level of 5.1×106 copies/mL at baseline to a median level of 2.4×103 copies/mL at week 48. Reduction magnitudes of HBV cccDNA in patients with normalized alanine aminotransferase levels and those undergoing HBeAg seroconversion were significantly greater than those in alanine aminotransferase-abnormal and HBeAg positive patients. Intrahepatic HBV cccDNA was decreased significantly after 48 weeks of treatment, but could not be eradicated. In conclusion, treatment of HBeAg-positive hepatitis B patients with entecavir for 48 weeks decreased serum and intrahepatic HBV cccDNA significantly, and the magnitude of HBV cccDNA reduction was related to total HBV DNA decrease, alanine aminotransferase normalization, and HBeAg seroconversion.
authors: Department of Laboratory Medicine, No. 6 Hospital of Dalian, Dalian, China.
authors: Ming
authors: M
authors: Shi
authors: Department of Laboratory Medicine, No. 6 Hospital of Dalian, Dalian, China.
authors: Wan-Li
authors: WL
authors: Sun
authors: Department of Laboratory Medicine, No. 6 Hospital of Dalian, Dalian, China.
authors: Yan-Yan
authors: YY
authors: Hua
authors: Department of Laboratory Medicine, No. 6 Hospital of Dalian, Dalian, China.
authors: Bo
authors: B
authors: Han
authors: Department of Laboratory Medicine, No. 6 Hospital of Dalian, Dalian, China.
authors: Long
authors: L
authors: Shi
mesh_terms: D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004270:DNA, Circular / Q000032:analysis / Q000097:blood / Q000235:genetics; D004279:DNA, Viral / Q000032:analysis* / Q000097:blood / Q000235:genetics; D005260:Female; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy*; D006513:Hepatitis B e Antigens / Q000032:analysis / Q000097:blood; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008099:Liver / Q000821:virology*; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D004270:DNA, Circular; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; C413685:entecavir; D006147:Guanine
references: Cell. 1986 Nov 7;47(3):451-60
references: 3768961
references: J Med Virol. 2003 Sep;71(1):24-30
references: 12858405
references: Am J Gastroenterol. 2005 May;100(5):1099-103
references: 15842584
references: Rom J Gastroenterol. 2005 Dec;14(4):373-7
references: 16400354
references: Hepatology. 2006 Sep;44(3):675-84
references: 16941693
references: J Antimicrob Chemother. 2006 Nov;58(5):1031-5
references: 16987866
references: World J Gastroenterol. 2004 Jan;10(1):82-5
references: 14695774
references: Lancet. 2003 Dec 20;362(9401):2089-94
references: 14697813
references: Gastroenterology. 2004 Jun;126(7):1750-8
references: 15188170
references: Hepatology. 2004 Sep;40(3):727-37
references: 15349913
references: Hepatology. 1985 Sep-Oct;5(5):728-34
references: 4029888
references: J Virol Methods. 2006 Dec;138(1-2):70-9
references: 16962180
references: J Viral Hepat. 2007 Jan;14(1):55-63
references: 17212645
references: Antivir Ther. 2006;11(7):909-16
references: 17302253
references: J Med Virol. 2013 Jun;85(6):987-95
references: 23588724
references: J Virol. 2000 Dec;74(24):11754-63
references: 11090175
references: Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68
references: 10704474
references: Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):373-83
references: 23477988
references: Clin Cancer Res. 2001 Jul;7(7):2005-15
references: 11448918
references: Ann N Y Acad Sci. 2001 Sep;945:195-206
references: 11708479
references: Biochem Biophys Res Commun. 2002 Aug 2;295(5):1102-7
references: 12135608
references: J Virol. 2003 Jan;77(1):68-76
references: 12477811
references: J Virol. 1997 Dec;71(12):9392-9
references: 9371599